This week in Physical Medicine & Rehabilitation
Nov 19, 2026
Does reducing the number of intradetrusor botulinum toxin type A injection sites affect efficacy and safety in patients with spinal cord injury?
In 44 patients with spinal cord injury and neurogenic detrusor overactivity, 200 units of botulinum toxin across 20 sites matched 30 sites on urodynamics, continence and safety at twelve weeks.
The Journal of Spinal Cord Medicine · 2026 · PubMed
This week’s highlights
Read the weekly briefing
This AudioScholar briefing is generated by artificial intelligence from PubMed abstracts for healthcare professionals and is not medical advice.
This week: fewer injection sites for bladder botulinum toxin after spinal cord injury, yoga for stiffness and walking in knee osteoarthritis, and why so many pediatric rehabilitation referrals never turn into a first visit.
Welcome to This Week in Physical Medicine & Rehabilitation. We're covering 10 papers this week: 3 in depth, 4 in brief, 3 quick signals.
Zheng and colleagues, in The Journal of Spinal Cord Medicine, ran a single-blind randomized trial at one spinal cord injury rehabilitation centre in China. They asked whether intradetrusor botulinum toxin type A needs thirty injection sites. Forty-four patients with spinal cord injury and neurogenic detrusor overactivity all received the same 200 unit dose, split across either thirty or twenty sites. At twelve weeks, both groups improved on urodynamic measures and on volume per catheterization, with no significant difference between the groups. Maximum detrusor pressure fell by about 32 centimetres of water with twenty sites and about 26 with thirty sites. Weekly incontinence episodes fell by more than half in both arms, and eight patients in the twenty-site group and seven in the thirty-site group became completely dry. Incontinence-specific quality of life improved similarly, and the authors report no loss of safety with fewer sites. The main limitation is size. Forty-four patients at one centre, followed for twelve weeks, cannot rule out a modest difference between techniques, and the trial does not address how long the effect lasts. What it adds is randomized evidence that, at a fixed dose, fewer injection sites gave a similar result, which the authors link to shorter procedures and better patient comfort [1].
Wang and colleagues, in the American Journal of Physical Medicine and Rehabilitation, pooled randomized and controlled intervention studies of yoga for knee osteoarthritis, searching six databases and using a three-level random-effects meta-analysis with sensitivity, influence, publication bias and GRADE assessments. Yoga improved stiffness with a moderate to large standardized effect, about two thirds of a standard deviation. Muscle strength and walking function improved with smaller, moderate effects, and the walking result held after one outlying study was removed. Quality of life did not improve significantly. Certainty of evidence was rated moderate for stiffness, strength and walking, and very low for quality of life. The most important limitation is that the analysis combined randomized trials with non-randomized controlled studies, and standardized effect sizes do not translate directly into points on any one clinical scale, so the size of benefit a patient would notice is hard to judge. Yoga programmes also vary widely in style and dose. What the review adds is moderate-certainty evidence that yoga improves stiffness, strength and walking in knee osteoarthritis, while its effect on quality of life remains uncertain [2].
Tanner and colleagues, in the Archives of Physical Medicine and Rehabilitation, used an explanatory sequential mixed methods design in a pediatric healthcare organization with six ambulatory rehabilitation clinics offering physical, occupational and speech-language therapy. They followed 8,533 referrals for children and adolescents up to eighteen years old between March 2021 and February 2022, then interviewed twelve parents from that cohort. Only about 43 percent of referrals led to services starting. Speech-language pathology had the lowest initiation rate, at about 37 percent, and feeding therapy the highest, at about 55 percent. Parents described intersecting barriers. Contextual factors included geographic availability, scheduling, and how professionals explained the need for services. Individual factors included prior rehabilitation experience, competing family priorities, access to early intervention, cost, transportation and a wait-and-see approach. The limitations are a single organization, a referral year that overlapped the pandemic period, and only twelve interviews to explain patterns across thousands of referrals. What the study adds is a measure of the gap between referral and care, with family accounts that point to sociodemographic disparities and to shared decision-making between referring provider and family as targets [3].
Now, four in brief.
In the Journal of NeuroEngineering and Rehabilitation, Chloé and colleagues ran a pilot pragmatic randomized trial in thirty-four people with subacute stroke, replacing a fifth of daily conventional therapy with immersive virtual reality for two weeks while keeping total therapy time equal. Both groups improved on every outcome, with no overall group effect. The virtual reality group did show a significantly greater gain on the Berg Balance Scale, and that gain correlated with the visual score on the Sensory Organization Test. Gait measures did not differ between groups. This is a small, short pilot, so the balance signal is preliminary [4].
A second stroke gait study pointed the other way. Lee and colleagues, in the Journal of Rehabilitation Medicine, ran an assessor-blinded crossover pilot in twenty people with chronic hemiparetic stroke, comparing haptic cane-assisted training with dose-matched conventional gait training. Fifteen participants completed both periods, adherence was about 97 percent, and there were no intervention-related adverse events. Self-selected gait speed did not differ between treatments, with a difference close to zero, and no secondary outcome differed. The training was feasible and safe, but this pilot found no added benefit, and the authors suggest testing outcomes closer to the proposed mechanism before any large trial [5].
Stokes and colleagues, also in the American Journal of Physical Medicine and Rehabilitation, followed 28 patients, 30 hips, with confirmed acetabular labral tears after a single ultrasound-guided intra-articular platelet-rich plasma injection, with the platelet product characterized before injection. Median scores on the twelve-item International Hip Outcome Tool rose from 50 at baseline to about 80 at three months and 76 at six months, exceeding the minimal clinically important difference at every timepoint. No serious adverse events occurred. Without a control group, natural history and placebo response cannot be separated from the treatment effect, and the authors call for a randomized trial [6].
In Disability and Rehabilitation, Lin and colleagues reviewed nine randomized trials with 348 patients with dementia or cognitive impairment, seven of them meta-analysed. Action observation therapy was associated with improved cognitive function, with a large standardized effect, along with better activities of daily living and naming. In patients with dementia without stroke, gait velocity and timed up-and-go also improved, and the cognitive benefit persisted at one month. The trials were few and small, and the authors frame the benefit as possible [7].
Three quick signals.
In Spinal Cord, Ben and colleagues scoped seventy randomized trials of motor training after spinal cord injury. Repetitious practice was reported in all trials but one, yet participant-centred goals appeared in only eight trials and feedback in twenty. This is a reporting review, not a test of effectiveness, but it limits replication of these interventions [8].
Also in Spinal Cord, Austin-Cliff and colleagues surveyed 339 people in Switzerland who were employed when injured. Changing employer after spinal cord injury was linked to roughly a quarter of the odds of good interest fit and about a third of the odds of good needs fit, while changing job type had no effect after adjustment. The data are observational and self-reported [9].
Başoluk and colleagues, in the American Journal of Physical Medicine and Rehabilitation, compared 108 men with radiographic axial spondyloarthritis with 108 age-matched controls. Sarcopenia by the ISarcoPRM definition affected about a third of patients versus about one in fourteen controls, and was tied to older age and higher body mass index, not spinal mobility. The design is cross-sectional and the estimate imprecise [10].
Stepping back across this week's papers, much of the evidence comes from pilot trials, single centres and small samples. Where an intervention was compared against an active, dose-matched alternative, both arms usually improved and the differences between them were small or absent. The larger within-group gains appeared in designs without a control arm. The week's firmest conclusions come from pooled analyses, and even there the certainty varied by outcome.
If you only have time for one paper this week, make it the injection-site trial from Zheng and colleagues [1]. It brings randomized evidence to a procedural detail of every intradetrusor botulinum toxin session in spinal cord injury, and it reopens the question of how many sites the standard technique needs.
That's your roundup for This Week in Physical Medicine & Rehabilitation. The full transcript and references are available on the episode page. See you next week.
If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And think of one colleague, in any specialty, who never has time to keep up with the literature. Tell them about AudioScholar: a ten-minute weekly for every specialty, to listen to in any podcast app, or to read at audioscholar dot C C.
This is an automated summary generated by artificial intelligence, which can make mistakes. Use it to choose which papers to read in full.
Get Physical Medicine & Rehabilitation every week
By email, Spotify, Apple or any podcast app.
Spot something worth flagging?